Antidepressant use in Australia has soared by almost 40 per cent over the past six years, with more than 16 million prescriptions issued.
GlaxoSmithKline (GSK), the pharmaceutical giant responsible for medications like Advair, Geritol and Zantac, has seen an increased number of lawsuits related to SSRI birth defects stemming from its popular antidepressant, Paxil.
At least one in six service members is on some form of psychiatric drug. And many troops are taking more than one kind, mixing several pills in daily “cocktails” — for example, an antidepressant with an antipsychotic to prevent nightmares, plus an anti-epileptic to reduce headaches — despite minimal clinical research testing such combinations.
Now Sen. Charles Grassley (R-Iowa), ranking Republican on the Senate Finance Committee, is investigating financial ties between Lilly and WebMD Health Corp. because of a WebMD TV ad exhorting people to undergo a Lilly depression screening.
In July, the Department of Health launched a review of the problem, after the House of Commons All-Party Group on Drug Misuse called for greater awareness, better doctor training and more treatment options. Although medical guidelines discourage doctors from prescribing benzodiazepine tranquilizers such as Valium for more than four weeks at a time, many patients still become addicted.